Inzon®

Indication : Treatment of infections caused by sensitive organisms to the following condition :
Respiratory tract infections (RTI) caused by S. pneumoniae, H. influenzae, S. aureus (penicillinase and non-penicillinase), S. pyogenes (Group α-ß-Hemolytic streptococci), Pseudomonas aeruginosa, Klebsiella pneumoniae, E. coli, Proteus mirabilis, Enterobacter sp.
Peritonitis and intra abdominal infections caused by E. coli, P. aeruginosa, anaerobic Gram-negative bacilli including Bacteroides fragilis.
Bacterial septicemia infections caused by S. pneumoniae, S. agalactiae, Proteus sp., Clostridium sp., and anaerobic Gram-positive cocci.
Skin and soft tissue infections caused by S. aureus, S. pyogenes, S. aeruginosa.
Urinary tract infections (UTI) caused by E. coli and Pseudomonas aeruginosa.
Reproductive tract infections, endometritis, pelvic caused by Neisseria gonorrhoeae, S. epidermidis, S. agalactiae, E. coli, Clostridium sp., Bacteroides sp., anaerobic Gram-positive cocci.

Composition : Each vial Inzon® Powder for IV/IM Injection 1 g contains Cefoperazone sodium equivalent to Cefoperazone 1 g.

Presentation : Inzon® Powder for IV/IM injection 1 g
Box, 1 vial @ 1 g

On medical prescription only.
Store below 25°C and dry place. Protect from light.

After reconstitution, Inzon® can be stored for up to 24 hours at temperature below 25°C without undergoing any significant physical or chemical changes.